Modified Simiao decoction (MSD) monotherapy is superior to anti-inflammatory drugs and/or uric acid-lowering drugs in treating gouty arthritis, and it can reduce uric acid (UA) and C-reactive protein (CRP) levels; regulate human metabolic disorders; and has no side effects [109–111]. The gene discussed is CRP; the disease is Other metabolic disease.